еНаука - преглед
Преглед према Аутор Genovese, Mark C
Приказ резултата 1 до 3 од 3
| Година | Наслов | Аутор(и) | Тип резултата | Мп-кат. |
|---|---|---|---|---|
| 2019 | Efficacy and Safety of Fenebrutinib, a BTK Inhibitor, Compared to Placebo in Rheumatoid Arthritis Patients with Active Disease Despite TNF Inhibitor Treatment: Randomized, Double Blind, Phase 2 Study | Cohen, Stanley B; Tuckwell, Katie; Kunder, Rebecca; Katsumoto, Tamiko R; Zhao, Rui; Berman, Alberto; Damjanov, Nemanja S; Fedkov, Dmytro; Jeka, Slawomir; Genovese, Mark C | Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2019 | Fenebrutinib Compared to Placebo and Adalimumab in Patients with Inadequate Response to Either Methotrexate Therapy Or Prior Tnf Therapy: Phase 2 Study | Cohen, Stanley B; Tuckwell, Katie; Katsumoto, Tamiko R; Zhao, Rui; Lee, Chin; Berman, Alberto; Damjanov, Nemanja S; Fedkov, Dmytro; Jeka, Slawomir; Genovese, Mark C | Конференцијски рад | Mp kategorija će biti prikazana naknadno. |
| 2013 | Oskira-2: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To Disease-Modifying Antirheumatic Drugs. | Dawes, Peter; Dimic, Aleksandar N; Genovese, Mark C; van, der Heijde Desiree; Jenkins, Martin; O'Brien, Chris; Oemar, Barry; Vencovsky, Jiri; Weinblatt, Michael | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |